Molecules / Eribulin / China

Eribulin API manufacturers in China

CAS 253128-41-5 ATC L01XX41 Updated 9 July 2026
17
China-based manufacturers with an active filing of 15 worldwide
Showing 9 of 17 China-based manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked China-based API manufacturers

01

Zhejiang Raybow Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for eribulin, filing since 2022. Its 2024 FDA inspection closed as NAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · NAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
02
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for eribulin, filing since 2023. Its 2024 FDA inspection closed as NAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · NAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
03

Wisdom Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for eribulin, filing since 2021. Its 2024 FDA inspection closed as NAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · NAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Chongqing Sintaho Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for eribulin, filing since 2023. Its 2025 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
06

BrightGene Bio-Medical Technology

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for eribulin, filing since 2020. Its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
09

Xiling Lab

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for eribulin, filing since 2022.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile

8 more manufacturers in China hold filings for eribulin

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

Lianyungang Runzhong PharmaceuticalWisdom PharmaceuticalChongqing Sintaho PharmaceuticalZenji Pharmaceuticals (Suzhou)BrightGene Bio-Medical TechnologySuzhou Tianma Specialty ChemicalsWuyan Pharmaceutical Technology (Shanghai)Xiling Lab
Open the full list with a free account

How this list is built

This page filters the worldwide Eribulin manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.

Map eribulin for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

All Eribulin manufacturers

Worldwide 15